在患有或没有恶化功能的患者中,强化缩血压控制
Xiaoli Xu1,2, Xiaoyun Zhang1,2, Siyu Wang1,2
1Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
European journal of preventive cardiology
|April 8, 2025
概括
密集的血压 (BP) 控制可能会增加功能恶化 (WRF),但它仍然可以降低心血管疾病 (CVD) 和WRF患者的死亡风险. 即使在WRF发生后,继续强化高血压治疗也有益.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 临床试验 临床试验
背景情况:
- 密集的系统血压 (BP) 控制降低了心血管疾病 (CVD) 的风险,但可能会增加功能恶化 (WRF).
- 在WRF发作后继续密集控制血压的好处尚未得到充分证实.
研究的目的:
- 评估在患有WRF的患者中持续强化血压治疗的疗效和安全性.
主要方法:
- 系统血压干预试验 (SPRINT) 的后期分析.
- 定义为≥30%的eGFR下降. 用于评估结果的时间更新的Cox比例危险模型.
- 在有或没有WRF的患者中,强化血压治疗与标准血压治疗进行了比较.
主要成果:
- 强化血压治疗增加了WRF风险,但显著降低了WRF患者的主要结局和全因死亡风险.
- 在没有WRF的患者中,强化BP治疗也降低了初级结局风险.
- 无论WRF状态如何,治疗组之间安全事件没有显著差异.
结论:
- 尽管增加了WRF风险,但密集的BP治疗对患有WRF的患者的心血管疾病和死亡率降低提供了显著的好处.
- 在患有WRF的患者中,应考虑强化血压控制,因为它不会增加不良事件.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
454
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
454
Hypertension and Regulation of Blood Pressure
1.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
329
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
329
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
404
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
404
Antihypertensive Drugs: Action of Diuretics
588
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
588
Heart Failure Drugs: Diuretics
298
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
298


